Lääketehdas Pfizerilla on parhaillaan yli 300 syytettä Neurontin nimisen epilepsialääkkeen haittavaikutusten piilottelusta. Neurontinin epäillään aiheuttavan itsemurhariskien lisääntymistä.
New York Times 29.1.2011
http://www.nytimes.com/2011/01/29/busin ... &sq=pfizer
Pfizer Told to Pay $142.1 Million Over Marketing of Epilepsy Drug
By BLOOMBERG NEWS
Published: January 28, 2011
* Sign In to E-Mail
o Yahoo! Buzz
Pfizer, the drug maker, has been ordered to pay a total of $142.1 million in damages for violating federal racketeering laws in the marketing of its epilepsy drug Neurontin.
Add to Portfolio
* Pfizer Inc
Go to your Portfolio »
Judge Patti B. Saris of United States District Court in Boston upheld a jury?s finding that the Kaiser Foundation Health Plan and Kaiser Foundation Hospitals deserved the award over their claims that Pfizer illegally promoted Neurontin for unapproved uses.
In her ruling on Thursday, Judge Saris tripled the jury?s award of $47.3 million under a provision of the Racketeer Influenced and Corrupt Organizations Act of 1970.
Kaiser officials claimed they were duped into believing that migraines and bipolar disorder could be treated effectively with Neurontin, approved in 1993 by the Food and Drug Administration for epilepsy.
Chris Loder, a Pfizer spokesman, said the company intended to appeal.
Kaiser, based in Oakland, Calif., claimed it was forced to pay $90 million more than it should have for the drug.
Pfizer currently faces more than 300 suits accusing it of illegally promoting Neurontin or hiding its health risks. Lawyers for former users of Neurontin contend the drug maker knew the medicine posed a suicide risk and failed to disclose it to patients and doctors.
The Warner-Lambert Company developed and marketed Neurontin for several years before Pfizer acquired the drug maker in 2000. Four years later, Warner-Lambert pleaded guilty and agreed to pay $430 million to resolve off-label marketing allegations by the Justice Department.